237 related articles for article (PubMed ID: 27277846)
1. Inflammatory Markers of CRP, IL6, TNFα, and Soluble TNFR2 and the Risk of Ovarian Cancer: A Meta-analysis of Prospective Studies.
Zeng F; Wei H; Yeoh E; Zhang Z; Ren ZF; Colditz GA; Tworoger SS; Su X
Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1231-9. PubMed ID: 27277846
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of circulating C-reactive protein, interleukin-6, and tumor necrosis factor α receptor 2 levels and risk of ovarian cancer.
Poole EM; Lee IM; Ridker PM; Buring JE; Hankinson SE; Tworoger SS
Am J Epidemiol; 2013 Oct; 178(8):1256-64. PubMed ID: 23966559
[TBL] [Abstract][Full Text] [Related]
3. Markers of systemic inflammation and colorectal adenoma risk: Meta-analysis of observational studies.
Godos J; Biondi A; Galvano F; Basile F; Sciacca S; Giovannucci EL; Grosso G
World J Gastroenterol; 2017 Mar; 23(10):1909-1919. PubMed ID: 28348498
[TBL] [Abstract][Full Text] [Related]
4. Circulating levels of C-reactive protein, interleukin-6 and tumor necrosis factor-α and risk of colorectal adenomas: a meta-analysis.
Zhang X; Liu S; Zhou Y
Oncotarget; 2016 Sep; 7(39):64371-64379. PubMed ID: 27608842
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC Cohort.
Ose J; Schock H; Tjønneland A; Hansen L; Overvad K; Dossus L; Clavel-Chapelon F; Baglietto L; Boeing H; Trichopolou A; Benetou V; Lagiou P; Masala G; Tagliabue G; Tumino R; Sacerdote C; Mattiello A; Bueno-de-Mesquita HB; Peeters PH; Onland-Moret NC; Weiderpass E; Gram IT; Sánchez S; Obon-Santacana M; Sànchez-Pérez MJ; Larrañaga N; Castaño JM; Ardanaz E; Brändstedt J; Lundin E; Idahl A; Travis RC; Khaw KT; Rinaldi S; Romieu I; Merritt MA; Gunter MJ; Riboli E; Kaaks R; Fortner RT
Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):951-61. PubMed ID: 25855626
[TBL] [Abstract][Full Text] [Related]
6. Circulating Inflammation Markers, Risk of Lung Cancer, and Utility for Risk Stratification.
Shiels MS; Katki HA; Hildesheim A; Pfeiffer RM; Engels EA; Williams M; Kemp TJ; Caporaso NE; Pinto LA; Chaturvedi AK
J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26220734
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein, interleukin-6, soluble tumor necrosis factor α receptor 2 and incident clinical depression.
Chocano-Bedoya PO; Mirzaei F; O'Reilly EJ; Lucas M; Okereke OI; Hu FB; Rimm EB; Ascherio A
J Affect Disord; 2014 Jul; 163():25-32. PubMed ID: 24836084
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin, TNF-α and inflammatory cytokines and risk of type 2 diabetes: A systematic review and meta-analysis.
Liu C; Feng X; Li Q; Wang Y; Li Q; Hua M
Cytokine; 2016 Oct; 86():100-109. PubMed ID: 27498215
[TBL] [Abstract][Full Text] [Related]
9. Levels of soluble tumor necrosis factor receptor 1 and 2, gender, and risk of myocardial infarction in Northern Sweden.
Carlsson AC; Jansson JH; Söderberg S; Ruge T; Larsson A; Ärnlöv J
Atherosclerosis; 2018 May; 272():41-46. PubMed ID: 29547707
[TBL] [Abstract][Full Text] [Related]
10. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers.
Seddon JM; George S; Rosner B; Rifai N
Arch Ophthalmol; 2005 Jun; 123(6):774-82. PubMed ID: 15955978
[TBL] [Abstract][Full Text] [Related]
11. High Levels of C-Reactive Protein Are Associated with an Increased Risk of Ovarian Cancer: Results from the Ovarian Cancer Cohort Consortium.
Peres LC; Mallen AR; Townsend MK; Poole EM; Trabert B; Allen NE; Arslan AA; Dossus L; Fortner RT; Gram IT; Hartge P; Idahl A; Kaaks R; Kvaskoff M; Magliocco AM; Merritt MA; Quirós JR; Tjonneland A; Trichopoulou A; Tumino R; van Gils CH; Visvanathan K; Wentzensen N; Zeleniuch-Jacquotte A; Tworoger SS
Cancer Res; 2019 Oct; 79(20):5442-5451. PubMed ID: 31462430
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor receptor 2 as a possible marker of COPD in smokers and ex-smokers.
Caram LMO; Ferrari R; Nogueira DL; Oliveira M; Francisqueti FV; Tanni SE; Corrêa CR; Godoy I
Int J Chron Obstruct Pulmon Dis; 2017; 12():2015-2021. PubMed ID: 28744116
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein concentrations and subsequent ovarian cancer risk.
McSorley MA; Alberg AJ; Allen DS; Allen NE; Brinton LA; Dorgan JF; Pollak M; Tao Y; Helzlsouer KJ
Obstet Gynecol; 2007 Apr; 109(4):933-41. PubMed ID: 17400857
[TBL] [Abstract][Full Text] [Related]
14. A Prospective Study of Inflammatory Markers and Risk of Endometriosis.
Mu F; Harris HR; Rich-Edwards JW; Hankinson SE; Rimm EB; Spiegelman D; Missmer SA
Am J Epidemiol; 2018 Mar; 187(3):515-522. PubMed ID: 28992341
[TBL] [Abstract][Full Text] [Related]
15. Plasma Inflammatory Markers and Risk of Advanced Colorectal Adenoma in Women.
Song M; Mehta RS; Wu K; Fuchs CS; Ogino S; Giovannucci EL; Chan AT
Cancer Prev Res (Phila); 2016 Jan; 9(1):27-34. PubMed ID: 26511487
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein, interleukin-6 and the risk of colorectal cancer: a meta-analysis.
Zhou B; Shu B; Yang J; Liu J; Xi T; Xing Y
Cancer Causes Control; 2014 Oct; 25(10):1397-405. PubMed ID: 25053407
[TBL] [Abstract][Full Text] [Related]
17. Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.
Trabert B; Pinto L; Hartge P; Kemp T; Black A; Sherman ME; Brinton LA; Pfeiffer RM; Shiels MS; Chaturvedi AK; Hildesheim A; Wentzensen N
Gynecol Oncol; 2014 Nov; 135(2):297-304. PubMed ID: 25158036
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of inflammatory biomarker levels and risk of early menopause.
Bertone-Johnson ER; Manson JE; Purdue-Smithe AC; Hankinson SE; Rosner BA; Whitcomb BW
Menopause; 2019 Jan; 26(1):32-38. PubMed ID: 29994968
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis.
Wang X; Bao W; Liu J; Ouyang YY; Wang D; Rong S; Xiao X; Shan ZL; Zhang Y; Yao P; Liu LG
Diabetes Care; 2013 Jan; 36(1):166-75. PubMed ID: 23264288
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of plasma inflammatory markers and risk of colorectal cancer in men.
Song M; Wu K; Ogino S; Fuchs CS; Giovannucci EL; Chan AT
Br J Cancer; 2013 May; 108(9):1891-8. PubMed ID: 23591192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
